Cartesian Therapeutics, Inc.
RNAC institutional ownership changes in Q2 2026: 44 institutions opened or added positions, 15 trimmed or exited. RNAC (Cartesian Therapeutics, Inc.) is held by 58 institutional investors as of Q2 2026. Top institutional shareholders: Squarepoint Ops LLC ($23.5M), BlackRock, Inc. ($8.5M), Vanguard Capital Management LLC ($5.8M). Institutions were buying, on balance.
Who's Trading
Latest move
Source dates: Price Nov 6, 2026 · Insiders Apr 6, 2026 · Activists Nov 6, 2026 · Congress none
Top Holders
| Action | ||||||
|---|---|---|---|---|---|---|
Increased | 2.3M(+0.7%) | $23.5M | 0.0% | +3.57% | 29 | |
Increased | 819,239(+36.7%) | $8.5M | 0.0% | -57.28% | 36 | |
Increased | 555,823(+36.4%) | $5.8M | 0.0% | -12.06% | 35 | |
Decreased | 368,429(-53.9%) | $3.8M | 0.0% | -64.53% | 0 | |
Increased | 356,525(+35.2%) | $3.7M | 0.0% | -64.41% | 34 | |
Increased | 356,456(+324.3%) | $3.7M | 0.0% | -31.91% | 43 | |
Increased | 309,887(+9.0%) | $3.2M | 0.0% | -12.32% | 29 | |
Increased | 296,293(+77.1%) | $3.1M | 0.0% | -23.10% | 40 | |
Increased | 249,212(+24.4%) | $2.6M | 0.0% | -69.60% | 32 | |
Decreased | 232,919(-7.3%) | $2.4M | 0.0% | -23.72% | 0 | |
Increased | 208,647(+52.5%) | $2.2M | 0.0% | -23.66% | 36 | |
First report | 200,905 | $2.1M | 0.0% | -38.48% | 0 | |
Increased | 105,698(+14.9%) | $1.1M | 0.0% | -63.51% | 29 | |
Increased | 91,854(+30.7%) | $957,119 | 0.0% | -10.38% | 32 | |
Increased | 87,317(+44.1%) | $909,843 | 0.0% | -14.05% | 23 | |
New | 84,624 | $881,782 | 0.0% | -38.48% | 34 | |
New | 81,828 | $852,648 | 0.0% | -38.48% | 34 | |
Increased | 80,572(+160.5%) | $839,560 | 0.0% | -27.00% | 40 | |
Increased | 63,977(+543.0%) | $666,640 | 0.0% | -36.37% | 40 | |
Increased | 63,454(+69.4%) | $661,191 | 0.0% | -39.61% | 36 |
Showing 1-20 of 66
| Insider | Trade | Traded |
|---|---|---|
| Hoge Elizabeth | Exercise 758K sh | |
| Kalayoglu Murat | Exercise 758K sh | |
| Singer Michael | Gift 7K sh | |
| Brunn Carsten | Sell $162K | |
| Davis Blaine | Sell $72K | |
| Miljkovic Milos | Sell $24K | |
| SPRINGER TIMOTHY A | Vest 3K sh | |
| Kalayoglu Murat | Vest 3K sh | |
| Brunn Carsten | Vest 143K sh | |
| Davis Blaine | Vest 37K sh |
| Filer | Stake | Filed |
|---|---|---|
| Barclays PLC | 0.0% | |
| Barclays PLC | 6.0% | |
| JPMORGAN CHASE & CO. | 4.8% | |
| FMR LLC | 3.0% | |
| Squarepoint Ops LLC | 8.3% | |
| JPMORGAN CHASE & CO. | 6.1% |
RNACCartesian Therapeutics, Inc.Continue exploring
Other Healthcare stocks held by institutions
UNHUnitedHealth Group Incorporated
LLYEli Lilly and Company
TMOThermo Fisher Scientific Inc
JNJJohnson & Johnson
DHRDanaher Corporation
ISRGIntuitive Surgical, Inc.
MRKMerck & Company, Inc.
ABBVAbbVie Inc.
BSXBoston Scientific Corporation
ABTAbbott LaboratoriesQuestions investors ask about RNAC
Who owns RNAC?
58 institutional investors held RNAC on June 30, 2026, led by Squarepoint Ops LLC ($23.5M), BlackRock, Inc. ($8.5M) and Vanguard Capital Management LLC ($5.8M).
How many hedge funds hold RNAC?
58 institutional investors reported RNAC in their 13F filings for the quarter ended June 30, 2026, $76.6M in all. 3 of them are rated Elite.
Are institutions buying or selling RNAC?
Buying, on balance. In Q2 2026, 44 institutions opened or added to positions in RNAC and 15 institutions trimmed or exited.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer